HDAX Therapeutics
- Biotech or pharma, therapeutic R&D
HDAX Therapeutics is a biotechnology company pioneering a novel approach to target HDAC6 to address critical unmet medical needs in cardiometabolic/renal and select neurological diseases.
June 16-19, 2025
Boston Convention & Exhibition Center
HDAX Therapeutics is a biotechnology company pioneering a novel approach to target HDAC6 to address critical unmet medical needs in cardiometabolic/renal and select neurological diseases.